Cover Image
市場調查報告書

胰臟癌:全球臨床實驗趨勢

Pancreatic Cancer Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 228234
出版日期 內容資訊 英文 1384 Pages
訂單完成後即時交付
價格
Back to Top
胰臟癌:全球臨床實驗趨勢 Pancreatic Cancer Global Clinical Trials Review, H1, 2017
出版日期: 2017年02月22日 內容資訊: 英文 1384 Pages
簡介

本報告提供全球胰臟癌治療藥臨床實驗上之相關調查,提供您各地區的臨床實驗數資料,實驗階段,實驗狀況,採用主題及各種贊助企業臨床實驗資料,臨床實驗主要的參與企業,有潛力的藥劑,最新臨床實驗相關新聞等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要5國的臨床實驗數量
    • 中南美主要5國的臨床實驗數量

G7各國臨床實驗數量:癌症治療藥臨床實驗上胰臟癌的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:癌症治療藥臨床實驗上胰臟癌的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

胰臟癌治療藥臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介概要

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Pancreatic Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Pancreatic Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Pancreatic Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Pancreatic Cancer Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Pancreatic Cancer
      • Feb 02, 2017: Targovax announces encouraging top line two-year survival data from TG01 clinical trial in resected pancreatic cancer patients
      • Jan 27, 2017: Redx outlines growing opportunity for Porcupine inhibitors
      • Jan 20, 2017: ARMO BioSciences Presents New Phase 1b Clinical Data for AM0010 in Advanced Pancreatic Cancer Patients at 2017 Gastrointestinal Cancers Symposium
      • Jan 20, 2017: Pamrevlumab Pancreatic Cancer Clinical Data Presented at ASCO 2017 Gastrointestinal Cancers Symposium
      • Jan 20, 2017: ChemoCentryx Announces Presentation of Data from Ongoing Phase Ib Clinical Trial of CCR2 Inhibitor CCX872 in Patients with Advanced Non-Resectable Pancreatic Cancer
      • Jan 17, 2017: BioLineRx Announces Initiation of Immuno-Oncology Phase 2 Study to Investigate Combination of BL-8040 and KEYTRUDA for Pancreatic Cancer
      • Jan 11, 2017: Celyad Announces Registration of the First Pancreatic Cancer Patient in its CAR-T NKR-2THINK Trial in Belgium
      • Jan 05, 2017: Halozyme Announces Phase 2 Study In Advanced Pancreas Cancer Meets Key Endpoints
      • Dec 23, 2016: Anti-AXL Biologic Increases Tumor Sensitivity to Radiation and Check-Point Inhibitors
      • Dec 22, 2016: Propanc Commences GLP-Compliant 28-Day Repeat-Dose Toxicity Study
      • Dec 12, 2016: PharmaCyte Biotech Secures Funding Opportunity for Pancreatic Cancer Clinical Trial
      • Dec 07, 2016: PharmaCyte Biotech Discusses Upcoming Clinical Trial in Pancreatic Cancer with First Principal Investigator
      • Dec 07, 2016: Sun BioPharma to Initiate Fifth Patient Cohort in its Dose Escalation Phase 1 Study of SBP-101 for Pancreatic Cancer
      • Dec 05, 2016: MabVax Therapeutics Expands Phase I Clinical Trial Investigation for Patients with Pancreatic Cancer to Include HonorHealth Research Institute
      • Dec 01, 2016: VAXIMM Presents Preclinical Data on VXM01 at EORTC-NCI-AACR Symposium
      • Dec 01, 2016: VAXIMM Presents Preclinical Data on VXM-04 at EORTC-NCI-AACR Symposium
      • Dec 01, 2016: PharmaCyte Biotech Moves Closer to Enrolling Patients in Pancreatic Cancer Clinical Trial
      • Nov 30, 2016: Promising results from new drug combination in patients with advanced solid tumors
      • Nov 30, 2016: Pre-clinical profile of Porcupine inhibitor RXC004 presented at EORTC-NCI-AACR 2016
      • Nov 29, 2016: New Research Validates both Single Agent and Synergistic Anticancer Activity for Aravive Biologics' Anti-AXL Candidate in Multiple Tumor Types
      • Nov 28, 2016: MabVax Therapeutics Enrolls First Patients in Expansion of Phase I Clinical Trial Treating Newly Diagnosed Pancreatic Cancer Patients
      • Nov 14, 2016: Provectus Biopharmaceuticals Announces Poster Presentation on PV-10 at Society for Immunotherapy of Cancer 2016 Annual Meeting
      • Nov 14, 2016: VCN Biosciences to present clinical data on systemic administration of VCN- 01 in pancreatic cancer patients at 28th EORTC-NCI-AACR SYMPOSIUM on Molecular Targets & Cancer Therapeutics
      • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
  • Source

List of Tables

  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region, 2017*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017*
  • Proportion of Pancreatic Cancer to Oncology Clinical Trials, G7 Countries (%), 2017*
  • Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
  • Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
  • Proportion of Pancreatic Cancer to Oncology Clinical Trials, E7 Countries (%), 2017*
  • Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
  • Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Phase, 2017*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
  • Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*

List of Figures

  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017*
  • Proportion of Pancreatic Cancer to Oncology Clinical Trials, G7 Countries (%), 2017*
  • Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
  • Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
  • Proportion of Pancreatic Cancer to Oncology Clinical Trials, E7 Countries (%), 2017*
  • Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
  • Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
  • Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*
  • GlobalData Methodology
Back to Top